1 ∣. BACKGROUND
The RHD gene located on the short arm of chromosome 1 encodes RhD, a highly immunogenic blood group protein.1 Several molecular mechanisms are known to cause a D-negative phenotype, with the RHD deletion being the most frequent one worldwide.2 Another mechanism involves deletions or insertions of, for example, one, two, or four nucleotides, which alter the ribosome reading frame, resulting in premature termination of translation. The total number of these frameshift variants in the RHD gene currently stands at 51.3 We report a 25-year-old Caucasian male donor with a D-negative phenotype harboring three single-nucleotide variants (SNVs), in RHD Exon 1, including a frameshift variant.
2 ∣. BRIEF METHODS
Ethylenediaminetetraacetic acid–anticoagulated whole blood sample was collected with consent in Springe, Germany. We have previously used and described all methods (Appendix S1, available as supporting information in the online version of this paper).
3 ∣. RESULTS
We analyzed a Ccdee blood donor harboring three novel SNVs in the RHD gene. His phenotype was reproducibly confirmed to be D-negative by adsorption/elution tests; two routine anti-D sera and two panels of 6 and 12 monoclonal anti-Ds, respectively, also tested negative (data not shown). Genomic DNA and cDNA sequencing revealed two transversion variants (c.4A>T and c.5G>C) and an insertion variant (c.6_7insG) in Exon 1 of the RHD gene (Figure 1A). The frameshift permits a full-length RHD transcript (Transcript 1, Figure 1B). Additional splicing isoforms that are normally seen in cDNA studies of RHD were also observed (Transcripts 2 to 5; Figure 1B). Zygosity testing revealed the donor to be hemizygous for the NG_007494.1(RHD):c.[4A>T;5G>C;6_7insG] allele with an RHD deletion in trans (RHD*01N.01). RH*Ce (RHCE*02) is the likely RHCE allele linked to the novel allele.
FIGURE 1.
Schematic representation of nucleotide substitutions and mRNA transcripts observed in the new RHD allele. The RHD gene comprises 10 exons (black bars) flanked by the upstream (blue) and downstream Rhesus box (red). The nucleotide sequences of the start codon (green box), premature termination codon (orange box) and the 3 variations (bold letters, with arrows) are shown along with their electropherograms, A. The resulting mRNA transcripts are symbolized as a concatenation of exons, B. Transcript 1 is full length and includes all 10 RHD exons (black outlined rectangles); Transcripts 2 to 5 lack different exons (gray outlined rectangles). GenBank entries: MT318152 (gDNA) and MT267527 (cDNA)
3.1 ∣. Population frequency
We calculated the frequency of NG_007494.1(RHD):c. [4A>T;5G>C;6_7insG] among the 460 711 first-time blood donors (921 422 chromosomes; Figure S1). Its frequency is 2.58 in 1 000 000 chromosomes (mean, 1 in 386 843 chromosomes; 95% confidence interval, 1 in 72 674 to 1 in 7 585 157, Poisson distribution, two sided).
4 ∣. SUMMARY
The novel NG_007494.1(RHD):c.[4A>T;5G>C;6_7insG] allele with an insertion of “G” between Nucleotides 6 and 7 in Exon 1 creates a premature termination codon at amino acid position 4. All five mRNA transcripts of different lengths and harboring a premature termination codon are predicted to translate a significantly truncated and dysfunctional RhD protein of only three amino acids. While the two SNVs c.4A>T and c.5G>C are missense variants when present alone, they still encode serine at amino acid position 2 of the RhD protein when present in tandem.
A possible mechanism for the origin of the NG_007494.1(RHD):c.[4A>T;5G>C;6_7insG] allele involves the error-prone human DNA polymerase zeta (pol ζ). Human pol ζ specializes in translesion DNA synthesis and lacks an intrinsic 3′-5′ exonuclease activity or proofreading function.4 Pol ζ has been shown to be involved in the generation of multinucleotide mutations in a single event, including tandem mutations.5 Around 13% of these tandem mutations have been associated with a de novo indel less than 10 bp away, as shown in yeast experiments.6 Such an event would explain the occurrence of tandem mutation at nucleotide positions c.4 and c.5 with an insertion of nucleotide “G” nearby in our allele.
Supplementary Material
ACKNOWLEDGMENT
We thank Marina U. Bueno, MT(ASCP)SBB, for serologic testing; and Traci D. Paige, MT(ASCP)SBB, for sample coordination. The Intramural Research Program of the National Institutes of Health (NIH) funded this work (project ID ZIA CL002128) at the NIH Clinical Center.
Footnotes
SUPPORTING INFORMATION
Additional supporting information may be found online in the Supporting Information section at the end of this article.
The views expressed herein do not necessarily represent the view of the National Institutes of Health, the Department of Health and Human Services, or the US federal government.
CONFLICT OF INTEREST
The authors declare no conflicts of interest.
REFERENCES
- 1.Flegel WA. Molecular genetics and clinical applications for RH. Transfus Apher Sci. 2011;44:81–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wagner FF, Moulds JM, Tounkara A, Kouriba B, Flegel WA. RHD allele distribution in Africans of Mali. BMC Genet. 2003; 4:14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Flegel WA, Srivastava K. Frameshift variations in the RHD coding sequence: Molecular mechanisms permitting protein expression. Transfusion. 2020. In press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Lawrence CW. Cellular functions of DNA polymerase zeta and Rev1 protein. Adv Protein Chem. 2004;69:167–203. [DOI] [PubMed] [Google Scholar]
- 5.Harris K, Nielsen R. Error-prone polymerase activity causes multinucleotide mutations in humans. Genome Res. 2014;24: 1445–1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Besenbacher S, Sulem P, Helgason A, et al. Multi-nucleotide de novo mutations in humans. PLoS Genet. 2016;12:e1006315. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

